secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oric Pharmaceuticals, Inc. (ORIC)
CIK:        0001796280
Form:       8-K
Filed at:   2024-03-29T23:59:59+00:00
Accession:  0001193125-24-082077
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ORIC Pharma boosts inducement equity plan by 650k shares to 1.15M total
-----------------------------------------------------------------------

- Compensation Committee approved amended 2022 Inducement Plan, adding 650,000 shares.
- Total shares reserved under plan now 1,150,000, for equity grants to new employees.
- Plan adopted without stockholder approval per Nasdaq inducement award rules.
- Awards may only go to individuals not previously employees/directors, as hiring inducement.
- Effective March 26, 2024; plan terms substantially similar to 2020 Equity Incentive Plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1796280/000119312524082077/0001193125-24-082077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1796280/000119312524082077/d802175d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-082077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer